Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8658-8669
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8658
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8658
Modality | Sensitivity | Specificity |
CA 19-9 | 70%-92% | 68%-92% |
CT | 77%-97% | 56%-89% |
Transabdominal ultrasound | 89% | 99% |
Percutaneous FNA | 62%-90% | 98%-100% |
ERCP | 49%-66% | 96% |
EUS-FNA | 75%-98% | 71%-100% |
EUS-FNB | 85%-95% | 86%-100% |
Pre-procedural considerations | General anesthesia may increase yield |
Goal platelet count greater than 50000 and INR less than 1.5 to reduce risk of bleeding | |
Hold antiplatelet and antithrombotic agents except aspirin or NSAIDS | |
Procedural Considerations | Take caution when duodenal diverticulum is present to reduce risk of perforation |
Use Doppler to identify vasculature prior to needle advancement to avoid bleeding | |
Use smaller (22 or 25) gauge needles for transduodenal FNA of the pancreatic head and uncinate | |
If core histology samples needed, use 19G (in body or tail) or core biopsy needles | |
Use suction | |
Use the “fanning technique” during FNA | |
Traverse the least amount of normal pancreatic tissue to reduce pancreatitis | |
Specimen Processing | Use on-site cytopathology or perform 7 needle passes |
- Citation: Storm AC, Lee LS. Endoscopic ultrasound-guided techniques for diagnosing pancreatic mass lesions: Can we do better? World J Gastroenterol 2016; 22(39): 8658-8669
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8658.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8658